The US Food and Drug Administration has published a Report to the US House Committee on Appropriations and the US Senate Committee on Appropriations regarding Cannabidiol (CBD). This long awaited report provides many answers, and poses many more questions. We hope you find this information valuable. There is a link to the full FDA report at the bottom of the page. The FDA has also updated their website’s CBD Regulation page. “Enforcement Policy: FDA is currently evaluating is

On April 3, 2019, the U.S. Food and Drug Administration opened a public comment period to discuss agricultural hemp and CBD. The purpose of this public comment period is to: Obtain scientific data and information about the safety, manufacturing, product quality, marketing, labeling, and sale of products containing cannabis or cannabis-derived compounds Docket N0 FDA-2019-N-1482 An Extended Deadline – July 16, 2019 The original ending date for this public comment period was